IPO Trending
VILINBIOSME / NSEListed

Vilin Bio Med Limited

Incorporated in 2005, Vilin Bio Med Limited is engaged in the domestic manufacturing of pharmaceutical products, supplying in bulk to pharmaceutical manufacturers, marketers, and traders who distribute them to end customers. The company’s product range includes Oral Liquids (Syrups, Suspensions, Dry Powders – both βeta and Non-βeta-Lactam), Tablets and Capsules (βeta and Non-βeta-Lactam), External Preparations, and Dry Powders. Vilin Bio Med operates its R&D center and manufacturing facility in Roorkee, Uttarakhand, ensuring quality and innovation in production. The company reported revenue of ₹1,121.91 lakhs in FY2022 and ₹1,171.88 lakhs in FY2021.

₹30 - ₹302.82x sub
Listed Price30.00
Listing Gain+0.00%
FinancialsBalance sheet and operational figures in Crores
Metric Breakdown

Revenue

Latest (Mar 2020)1682.41 Cr
Growth+86.2%
Revenue Trend (₹ in Crores)
0.0644.91.3k1.9kDec 2022Mar 2022Mar 2021Mar 2020
PeriodRev (Cr)PAT (Cr)AssetsDebt
Mar 20201,682.4116.221,400.60453.41
Mar 20211,171.88 12.131,389.14551.58
Mar 20221,121.913.351,355.83529.96
Dec 2022903.43128.081,687.11617.71
Key Performance Indicators (KPIs)
PeriodEPSROEROCEP/E (Pre)P/E (Post)
Values0.1014.76%8.58%24.590